CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 69 filers reported holding CABALETTA BIO INC in Q1 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $321,675 | +117.7% | 21,135 | +84.7% | 0.00% | – |
| Q2 2023 | $147,729 | – | 11,443 | +114330.0% | 0.00% | – |
| Q3 2021 | $0 | – | 10 | +11.1% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 9 | -99.9% | 0.00% | – |
| Q1 2021 | $93,000 | -18.4% | 8,380 | -8.6% | 0.00% | – |
| Q4 2020 | $114,000 | +60.6% | 9,169 | +39.5% | 0.00% | – |
| Q3 2020 | $71,000 | +7.6% | 6,573 | +10.6% | 0.00% | – |
| Q2 2020 | $66,000 | +340.0% | 5,943 | +189.8% | 0.00% | – |
| Q1 2020 | $15,000 | -50.0% | 2,051 | -6.0% | 0.00% | – |
| Q4 2019 | $30,000 | – | 2,183 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,106,000 | $32,053,320 | 21.20% |
| COMMODORE CAPITAL LP | 2,525,753 | $38,441,961 | 4.49% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $30,440,000 | 3.40% |
| VR Adviser, LLC | 1,973,253 | $30,032,911 | 3.16% |
| Cormorant Asset Management, LP | 2,879,424 | $43,824,833 | 2.56% |
| Velan Capital Investment Management LP | 150,000 | $2,283,000 | 1.84% |
| Redmile Group, LLC | 1,774,252 | $27,004,115 | 1.28% |
| TCG Crossover Management, LLC | 486,795 | $7,409,020 | 1.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,340,118 | $35,616,596 | 0.78% |
| Integral Health Asset Management, LLC | 330,000 | $5,022,600 | 0.70% |